论文部分内容阅读
目的:探讨熊去氧胆酸治疗婴儿胆汁淤积症临床效果。方法:选择我院2015年05月～2017年03月收治的122例婴儿胆汁淤积症患儿作为实验对象;所有患儿选择数字奇偶法分组;对照组与观察组分别施以常规保肝药治疗以及熊去氧胆酸治疗;对胆汁淤积症疗效回顾性分析。结果:观察组临床疗效(98.36%)同对照组(73.77%)比较,提高程度尤为显著(P<0.05)。结论:对于胆汁淤积症婴儿施以熊去氧胆酸治疗,在获得显著胆汁淤积症疗效基础上,优化胆汁淤积症患儿的生存能力。
Objective: To investigate the clinical effect of ursodeoxycholic acid in the treatment of infantile cholestasis. Methods: A total of 122 infants with cholestasis of infants who were treated in our hospital from May 2015 to March 2017 were selected as experimental subjects. All patients were divided into two groups according to the number parity method. The control group and observation group were treated with conventional hepatoprotective drugs And ursodeoxycholic acid treatment; retrospective analysis of the efficacy of cholestasis. Results: The clinical efficacy of the observation group (98.36%) was significantly higher than that of the control group (73.77%) (P <0.05). CONCLUSIONS: Ursodeoxycholic acid is administered to infants with cholestasis and the viability of children with cholestasis is optimized based on the efficacy of significant cholestasis.